NCT01097408View on ClinicalTrials.gov

Pharmacokinetics of AZD7295 Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

August 31, 2010

Conditions
Healthy
Interventions
DRUG

AZD7295

Up to 650mg AZD7295 capsules per dose. To be given 2 or 3 times daily for 5 days.

DRUG

Placebo comparator

Placebo capsules

Trial Locations (1)

Unknown

Quotient Clinical Research, Nottingham

Sponsors

Lead Sponsor

Arrow Therapeutics
All Listed Sponsors
lead

Arrow Therapeutics

INDUSTRY

NCT01097408 - Pharmacokinetics of AZD7295 Capsules | Biotech Hunter | Biotech Hunter